Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, Reduced, 2025 Q3

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Reduced

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q3 2025: Stock VERONA PHARMA PLC; Country of operation —; Class SPONSORED ADS; Shares before 1,396,644.
  • Q3 2025: Stock GRUPO SUPERVIELLE S.A.; Country of operation Argentina; Class SPONSORED ADR; Shares before 588,412.
  • Q3 2025: Stock QUANTASING GROUP LTD; Country of operation Cayman Islands; Class ADS; Shares before 82,219.
  • Q3 2025: Stock THE9 LTD; Country of operation Cayman Islands; Class SPON ADS; Shares before 43,964.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2025VERONA PHARMA PLC
CUSIP 925050106
—SPONSORED ADS1,396,644461,869-934,775$132,094,590$49,286,041-$82,808,5492025-11-14
Q3 2025GRUPO SUPERVIELLE S.A.
CUSIP 40054A108
ArgentinaSPONSORED ADR588,412264,211-324,201$6,231,283$1,307,844-$4,923,4392025-11-14
Q3 2025QUANTASING GROUP LTD
CUSIP 74767N107
Cayman IslandsADS82,21914,501-67,718$776,969$130,799-$646,1702025-11-14
Q3 2025THE9 LTD
CUSIP 88337K401
Cayman IslandsSPON ADS43,96412,464-31,500$342,040$132,492-$209,5482025-11-14
Q3 2025NIP GROUP INC
CUSIP 654503101
—SPONSORED ADS106,10935,169-70,940$259,967$61,897-$198,0702025-11-14
Q3 2025PICOCELA INC
CUSIP 71989C109
—SPONSORED ADS108,20172,766-35,435$175,286$32,235-$143,0512025-11-14
Q3 2025XCHG LTD
CUSIP 98370X103
—SPONSORED ADS62,01717,491-44,526$82,483$22,563-$59,9202025-11-14
Q3 2025IHUMAN INC
CUSIP 45175B109
—ADS COMMON35,38716,158-19,229$88,468$46,697-$41,7712025-11-14
Q3 202517 ED & TECHNOLOGY GROUP INC
CUSIP 81807M304
—SPONSORED ADR38,15911,726-26,433$83,568$50,187-$33,3812025-11-14
Q3 2025GRUPO AVAL ACCIONES Y VALORE
CUSIP 40053W101
ColombiaSPONSORED ADS74,38973,300-1,089$209,033$241,890+$32,8572025-11-14
Q3 2025BIOLINE RX LIMITED
CUSIP 09071M304
—SPONSORED ADR14,95410,020-4,934$68,340$37,876-$30,4642025-11-14
Q3 2025EDAP TMS S A
CUSIP 268311107
FranceSPONSORED ADR50,62148,251-2,370$83,018$111,460+$28,4422025-11-14
Q3 2025BRASILAGRO COMPANHIA BRASILE
CUSIP 10554B104
BrazilSPONSORED ADR68,43263,494-4,938$262,095$246,357-$15,7382025-11-14
Q3 2025ZKH GROUP LTD
CUSIP 98877R104
Cayman IslandsSPONSORED ADS44,14043,048-1,092$135,510$122,687-$12,8232025-11-14
Q3 2025LIGHTINTHEBOX HLDG CO LTD
CUSIP 53225G201
—SPONSORED ADR25,73118,529-7,202$29,513$38,911+$9,3982025-11-14
Q3 2025AMTD IDEA GROUP
CUSIP 00180G304
—SPON ADS41,91831,607-10,311$41,247$35,558-$5,6892025-11-14
Q3 2025VALNEVA SE
CUSIP 92025Y103
FranceSPONSORED ADS35,73816,410-19,328$201,920$200,202-$1,7182025-11-14